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Abstract. Granule membrane protein-140 (GMP140)
is an inducible receptor for myeloid leukocytes on ac-
tivated platelets and endothelium. Like other selectins,
GMP140 recognizes specific oligosaccharide ligands.
However, prior data on the nature of these ligands are
contradictory. We investigated the structural features
required for ligand interaction with GMP-140 using
purified GMP-140, cells naturally expressing specific
oligosaccharides, and cells expressing cloned glycosyl-
transferases. Like the related selectin endothelial
leukocyte adhesion molecule-1 (ELAM-1), GMP-140
recognizes a(2-3)sialylated, a(1-3)fucosylated lactos-
aminoglycans on both myeloid and nonmyeloid cells,
G
ANULE membrane protein-140 (GMP-140)', also
known as PADGEM protein or CD62, is an inte-
gral membrane glycoprotein located in secretory
granules of platelets and endothelium (Stenberg et al., 1985 ;
Berman et al ., 1986; McEver et al ., 1989; Bonfanti et al .,
1989) . Upon stimulation of these cells, GMP140 is rapidly
translocated to the plasma membrane (McEver and Martin,
1984; Hsu-Lin et al., 1984; Hattori et al., 1989 ; McEver et
al ., 1989), where it functions as a receptor for neutrophils
and monocytes (Larsen et al., 1989; Geng et al., 1990;
Hamburger and McEver, 1990).
GMP-140 belongs to the selectin family of structurally
related molecules that regulate leukocyte adhesion to plate-
lets and/or endothelium during inflammation (Johnston et
al., 1989 ; McEver, 1991). The other known selectins are
ELAM-1 (endothelial leukocyte adhesion molecule-1), a
cytokine-inducible endothelial cell receptor for neutrophils
and monocytes (Bevilacqua et al., 1989 ; Hession et al.,
1990), and the peripheral lymph node lymphocyte homing
receptor (murine Mel 14 antigen or human Leu 8 anti-
gen/LAM-1/LECAM-1) (Siegeluran et al ., 1989; Lasky et
al ., 1989) .
1. Abbreviations usedin thispaper: ELAM, endothelial leukocyte adhesion
molecule; GMP, granule membrane protein; NDV, Newcastledisease virus.
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including the sequence Neu .5ACa2-3Gal0l-4(Fucal-3)
GlcNAcß-R (sialyl Lewis x). Recognition requires si-
alic acid, because cells expressing large amounts of
Lewis x, but not sialyl Lewis x, do not interact with
GMP-140. Although sialyl Lewis x is expressed by
both myeloid HL-60 cells and CHO cells transfected
with an al-3/4 fucosyltransferase, GMP140 binds with
significantly higher affinity to HL-60 cells. Thus, the
sialyl Lewis x tetrasaccharide may require additional
structural modifications or specific presentations in or-
der for leukocytes in flowing blood to interact rapidly
and with high affinity to GMP-140 on activated plate-
lets or endothelium.
The selectins all contain NH2-terminal lectin domains
homologous to Cat+-dependent lectins (Drickamer, 1988)
and require Cat+ to mediate cell adhesion (McEver, 1991),
suggesting that they might bind to oligosaccharides on op-
posing cells. Several recent studies support this hypothesis
(reviewed in Brandley et al ., 1990; Springer and Lasky,
1991) . Interactions of LECAM-1 with high endothelial ven-
ules are abolished by high concentrations of charged saccha-
rides and by pretreatment of endothelium with neuramini-
dase, suggesting that the molecule binds to sialylated
oligosaccharides (Rosen et al., 1985; True et al., 1990) .
ELAM-1 binds to a group of a(2-3)sialylated, a(1-3)fuco-
sylated lactosaminoglycans on myeloid cells, of which one
appears to be the tetrasaccharide sialyl Lewis x (sialyl Lex;
Neu5Aca2-3Galol-4[Fucal-3]GlcNAco-R) (Lowe et al.,
1990; Goelz et al., 1990 ; Phillips et al., 1990; Walz et al.,
1990; Tiemeyer et al., 1991) .
Conflicting data have been reported concerning the carbo-
hydrate determinants recognized by GMP-140. Interactions
of myeloid cells with thrombin-activated platelets and GMP-
140-transfected COS cells were partially inhibited by certain
anti-CD15 mAbs, which bind to nonsialylated oligosaccha-
rides containing the Lex antigen (Galßl-4[Fucal-3]Glc-
NAcß-R), and by high concentrations of soluble oligosac-
charides containing the Lex structure (Larsen et al., 1990) .
557However, binding of
[1211]GMP140 to neutrophils was not
inhibited by large concentrations of an affinity-purified anti-
CD15 mAb (82115) or by a multivalent Lex-BSA conjugate
(Moore et al., 1991). Furthermore, treatment of myeloid
cells with neuraminidases prevented rosetting of activated
platelets (Corral et al., 1990) and binding of [1211]GMP140
(Moore et al., 1991), indicating that the ligand for GMP-140
contains sialic acid residues that are critical for recognition.
Pretreatment of neutrophils with neuraminidase from the
Newcastle disease virus (NDV), which cleaves a2-3 but not
a2-6 linkages, significantly reduced specific binding of
[1211]GMP140 to neutrophils, suggesting that at least some
of the critical linkages are of the a2-3, type (Moore et al.,
1991) . However, Corral et al. (1990) reported that plate-
let rosetting was not inhibited by pretreatment of myeloid
cells with the NDV enzyme and therefore concluded that
an a(2-6)-linked sialic acid was required for recognition by
GMP-140.
To better characterize the determinants required for.oligo-
saccharide binding to GMP140, we examined the interaction
of cells expressing different cell surface oligosaccharides
with GMP-140. We find that GMP140, like ELAM-1, binds
to a(2-3)sialylated, a(1-3)fucosylated lactosaminoglycans.
However the preferred ligand for GMP140 may be more
complex than the basic sialyl Lex tetrasaccharide. Like pre-
viously characterized plant and animal lectins, GMP-140
may bind with variable affinity to a range ofoligosaccharides
that differ in structure or orientation on the cell surface.
Materials and Methods
Reagents
GMP-140 was purified from outdated human platelets obtained from the
Oklahoma Blood Institute and the American Red Cross of Tulsa as previ-
ously described (Moore et al., 1991). The anti-GMP-140 mAbs S12 and GI
were produced and characterized as previously described (McEver and
Martin, 1984; Geng et al., 1990). Neuraminidase from Arthrobacter urea-
faciens, diisopropyl fluorophosphate (DFP), diphenyl carbamyl chloride-
treated trypsin (DPCC-trypsin, type XI, from bovine pancreas, 7,500
U/mg), goat anti-mouse IgM conjugated with alkaline phosphatase, p-nitro-
phenyl phosphate, and poly-L-lysine (mol wt 63,000) were purchased from
Sigma Chemical Co. (St. Louis, MO). [311]Methionine/cysteine (1,017 Ci/
mmol) was obtained from ICN Pharmaceuticals, Inc. (Irvine, CA) and
carrier-free Na121I (13.7 mCi/pg) was purchased from Amersham Corp.
(Arlington Heights, IL). FITC-anti-LeuMI (anti-Lex/CD15 monoclonal
IgM) was purchased from Becton-Dickinson (Mountain View, CA). The
murine anti-Le" IgM mAb, 82115 (JanowskaWieczorek et al., 1984) was
a gift from Murray Ratcliffe (Chembiomed, Edmonton, Alberta). An HPLC-
purified (Fukushima et al., 1984) mouse monoclonal IgM, CSLEXI, spec-
ific for the sialyl Lex determinant was kindly provided by Dr. Paul Terasaki
(University of California Medical School, Los Angeles, CA).
Cells
Human HL-60 promyelocytic cells, HT-29 human colon carcinoma cells,
and Lec8 CHO cells were obtained from the American Type Culture Col-
lection (Rockville, MD). HL-60 and K562 cells were maintained in culture
in RPMI-1640 supplemented with 10% FCS, 100 U/ml penicillin, and 100
Aglml streptomycin. HT-29 cells were maintained in culture in McCoy's 5a
medium supplemented with 10% FCS. The CHO cell line Ade-C was ob-
tained and cultured as described previously (Smith et al ., 1990). CHO and
Lec8 CHO cells (Stanley, 1985; Deutscher and Hirschberg, 1986) were
grown in a-modified Eagles' medium (a-MEM) supplemented with 10%
FCS. NeoLewis CHO cells, initially designated as CHO-FT cells (Lowe et
al., 1990), and Clone 3 CHO cells (Smith et al., 1990) were cultured in
a-MEM/10% FCS supplemented with G-418 (Gibco Laboratories, Grand
Island, NY) at 400 pg/ml ofactive drug. F9 teratocarcinoma cells were cul-
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tured and induced to differentiate with retinoic acid (RA/F9) as described
previously (Cummings and Mattox, 1988).
P5SJMethionine/Cysteine Labeling ofCells
All adherent cell lines were grown to -70% confluency and metabolically
labeled for 16 h with 50-100 ACi/ml of ["Slmethionine/cysteine . CHO,
HL-60, and HT29 cells were labeled, respectively, in low methionine (10%
methionine) a-MEM/10% FCS, RPMI 1640/10% FCS, and McCoy's 5a/
10% FCS. Adherent cells were collected by brief trypsinization for 2 min
at room temperatureusing 0.25 % trypsin(1,800 U/ml) in Hank's buffer con-
taining 2 mM EDTA. Radiolabeled cells were washed three times with
0.15 M NaCl, 10 mM Hepes, pH 7.4 (HBS) and suspended in the following
buffers. CHO cell lines were suspended in a-MEM/1% BSA, whereas
HT-29 cells were resuspended in McCoy's 5a/1% BSA. Metabolically radio-
labeled HL-60 cells grown in suspension were pelleted by centrifugation
and washed three times with FIBS and resuspended in RPMI-1640/1% BSA.
CellAdhesionAssay
Microtiter wells (Immulon 2 RemovawelITM strips from Dynatech Labora-
tories, Inc., Alexandria, VA) were coated with GMP-140 (0-10 Ag/ml) in
50-100 Al of PBS overnight at 4°C. The wells were washed three times with
PBS or FIBS to remove unbound GMP-140, then blocked with 1% BSA in
PBS or FIBS for 1 h at room temperature. Approximately 10° radiolabeled
cells were added and incubated for 1 h on an oscillating platform at room
temperature. Each well was gently washed twice with FIBS and the amount
of bound radioactivity determined by liquid scintillation counting. All as-
says were performed in duplicate unless indicated. The cell number was es-
timated by determining the protein content in aliquots of 1% Triton X-100
lysate ofadherent cells using the BCA protein assay (Pierce, Rockford, IL) .
A standard curve was established by determining the relationship between
protein and cell number, estimated by manual cell counts using a hemocy-
tometer. For certain experiments 10 pg/ml (final concentration) of anti-
GMP-140 mAb were included in the cell suspensions before the assay. In
other experiments, [33S]methionine/cysteine-labeled NeoLewis CHO cells
or HL-60 cells (106 cells/ml) were preincubated for 30 min at 4°C with
anti-sialyl Le' (CSLEX1), anti-Lex (82H5) (final concentration of 10-50
hg/ml), or buffer alone. Aliquots of the cell suspensions (50 A1, 5 x 10°
cells) were then transferred to microliter wells coated with GMP-140 and
cell adhesion was determined as described above. All experimentswere per-
formed in duplicate or triplicate.
Enzymatic ReatmentofHL-60 Cells andNeoLewis
CHO Cells
HL-60 cells and NeoLewis CHO cells were incubated in 0.15 M NaCl, 10
mM Hepes, pH 6.5, 5 mM CaC12, for 1 h at 37°C with 1.0 U/ml of Ar-
throbacter ureafaciens neuraminidase. Control cells were incubated under
identical conditions with enzyme that had been heat inactivated for 20 min
at 100°C. For trypsin treatment, NeoLewis CHO cells suspended in FIBS
were incubated for 10 min at 37°C with 0.1% DPCC-trypsin (7,500 U/ml).
Control cells were incubated under identical conditions with DPCC-trypsin
that had been irreversibly inactivated with DFP. After trypsin treatment,
cells were chilled on ice and DFP added to 2 mM final concentration to
inactivate the enzyme. After treatment with neuraminidase or trypsin the
cells were washed twice with ice-cold FIBS before determination of adhe-
sion or antibody binding.
Binding ofFluidphase [t211]GMR140 to Cells
GMP-140 (50 Ag) was radioiodinated by the chloramine T method
(McConahey and Dixon, 1980) and separated from free 1211 by Sephadex
G-25 chromatography as previously described (Moore et al., 1991) . The
specific activity of the [I21í]GMP-140 was -6.7 ACi/Ag. NeoLewis CHO
cells were detached with trypsin/EDTA, washed, and incubated ina-MEM/
1% FCS at 37°C for 1 h as a recovery period. The NeoLewis CHO and HL-
60 cells were washed three times with HBS and then 1.76 x 101 cells
were added to 0.5-ml polypropylene microfuge tubes containing increasing
amounts of [121I]GMP-140 in HBS/0.1% BSA, 1.82 mM CaC12, 0.8 mM
MgCl2. After incubation for 2 h at 4°C, 50 Al of 1:9 Apiezon:dibutyl-
phthalate was added and the tubes were centrifuged at 16,000 g at 4°C for
5 min. After centrifugation, the upper phase and most of the oil layer was
aspirated from each tube, and the tip containing the cell pellet was cut off.
The amount of bound 1211 was determined with a gamma counter. Specific
558binding of GMP-140 was calculated by subtracting the radioactivity bound
to thecells in the presence of EDTA from that bound in the presence ofcal-
cium. The apparent Ka for [I 25í]GMP-140 binding to cells was determined
as previously described (Cummings and Mattox, 1988). All assays were
performed in duplicate.
CellSurfaceExpression ofSialyl Lexand LexAntigens
Solid-phase inununoassays were performed according to the method of
Heusser et al. (1981). Briefly, 100 A1 of 10 kg/ml poly-L-lysine was added
to microtiter wells. After incubationat 37°C for 1 h, the wells were washed
with PBS, and 100 Al of cell suspension (2.5 x 106 cells/ml) was added
to each well. The microtiter plates were centrifuged at 100 g for 5 min at
4°C in a Sorvall RT6000 centrifuge. The supernatants were removed and
100 Al of 0.25% glutaraldehyde in PBS was added and incubated at 4°C
for 5 min. The wells were then washed three times with PBS and blocked
with PBS/1% BSA at room temperature for 1 h. Anti-sialyl Lex (CSLEXI)
or anti-Le" (anti-LeuMI) mAbs, diluted in PBS/1% BSA, were added to
the microtiter wells and incubated for 2 h at room temperature. After the
wells were washed three times with PBS/1% BSA, goat anti-mouse IgM
(k-chain specific) conjugated with alkaline phosphatase (1:1,000 dilution in
PBS/1% BSA) was added to each well and incubated an additional 1 h at
room temperature. The wells were then washed twice with PBS/1% BSA
and once with 0.1 M NaHC03, pH 9.6. After washing, 100 t11 of 1 mg/ml
p-nitrophenyl phosphate in 0.1 M NaHC03, pH 9.6 was added to each well
and incubated for 2 h at room temperature or overnight at 4°C. The optical
density at405 run was determined on 90-p1 aliquots using an automated mi-
crotiter plate reader (Model EL 309; Biotech Research Labs Inc., Rock-
ville, MD). The surface expressionofthese antigens was confirmed in some
cases by agglutination assays (Cummings and Mattox, 1988).
Results
HL-60CellBinding toGMP-140
To investigate the interaction of GMP-140 with animal cell
lines expressing different surface carbohydrate determinants,
we measured binding of ["S]methionine/cysteine-labeled
cells to purified GMP-140 immobilized on microtiter plates.
To validate the assay, we first tested the promyelocytic cell
line, HL-60, which is known to carry the ligand for GMP-
140 (Larsen et al ., 1989; Geng et al., 1990). HL-60 cells
bound to GMP-140 in a Cal+-dependent manner in propor-
tion to the amount of GMP-140 immobilized (Fig. 1 A) .
These results are consistent with previous studies in which
adhesion of myeloid cells to immobilized GMP-140 was
measured with a myeloperoxidase assay (Geng et al ., 1990) .
NeoLewis CHO CellBinding to GMP-140
Complex-type Asn-linkedoligosaccharides in CHO cell gly-
coproteins contain N-acetyllactosamine structures which
terminate primarily in the sequence Neu5Aca2-3Galßl-4-
[G1cNAcß1-3Galßl-4]nGLcNAc-R, where n = 0 to 3 (Li et
al ., 1980; Merkle and Cummings, 1988; Smith et al, 1990) .
There are no glycoprotein oligosaccharides containing the
isomeric 3Galßl-3GIcNAcßl oligosaccharides. All of the
sialic acid in complex-type Asn-linked oligosaccharides is
attached a2-3, rather than a2-6, to galactosyl residues (Mer-
kle and Cummings, 1988; Lee et al ., 1989). Moreover, the
known Ser/Thr-linked oligosaccharides in secreted and sur-
face glycoproteins are simple mono- and disialylated deriva-
tives of GaI01-3GONAcca1-Ser/Thr (Sasaki et al., 1987; Se-
guchi et al., 1991) . Finally, CHO cells synthesize only one
major ganglioside, GM3, and the neutral glycolipids are
lactosylceramide and glucosylceramide (Briles et al., 1979 ;
Smith et al., 1990).
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Figure 1. Binding of HL-60
cells and NeoLewis CHO cells
to immobilized GMP-140.
[35S]Methionine/cysteine-la-
beled HL-60 cells and Neo-
Lewis CHO cells were in-
cubated in microtiter wells
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The parental CHO cells used in this study were the Ade-C
line, selected because they express no detectable a(1-3)fuco-
syltransferase activity (Oates and Patterson, 1977; Van Keu-
ren et al., 1986). The NeoLewis CHO cells were prepared
by permanently transfecting Ade-C cells with cDNA for the
human GDPFuc:Galßl-3/4G1cNAc(al-3/4 to G1cNAc)c«I-
3/4 fucosyltransferase (Lowe et al., 1990) . In contrast to pa-
rental CHO cells, NeoLewis CHO cells express surface
sialyl Lex determinants (Neu5Aca2-3Galßl-4[Fucal-3]Glc-
NAcß-R) and a variety of sialylated and polyfucosylated
poly-N-acetyllactosanline-type structures (Lowe et al., 1990).
Another CHO cell line, designated Lec8 CHO, is deficient
in the transporter for UDPGaI and consequently lacks galac-
tosylated and sialylated glycoconjugates (Stanley, 1985 ;
Deutscher and Hirschberg, 1986) . Finally, Clone 3 CHO
cells were permanently transfected with the murine gene for
UDPGal:,8-D-Gal al-3 galactosyltransferase and synthesize
glycoconjugates containing the terminal sequence Galal-
3Galßl-4G1cNAc-R (Smith et al., 1990).
Of the four CHO cell lines tested, only NeoLewis CHO
cells bound to immobilized GMP-140 in a calcium-dependent
manner (Fig. 1 Band Table I). Fig. 2 demonstrates that adhe-
sion was specific for GMP-140 because it was inhibited by
Gl, a mAb to GMP-140 thatblocks interactions with myeloid
cells, but not by S12, a mAb to GMP-140 that does not block
leukocyte recognition (Geng et al., 1990; Hamburger and
McEver, 1990; Moore et al ., 1991) . These results demon-
strate that expression of the al-3/4 fucosyltransferase and
synthesis of Lex-related lactosaminoglycans are required
for interactions of GMP-140 with cells.
Correlation ofSialyl LexExpression with CellBinding
to ImmobilizedGMP-140
Pretreatment of myeloid cells with broad spectrum neur-
aminidases prevents binding to GMP-140 (Fig. 3 A and Cor-
ral et al., 1991; Moore et al., 1991). Fig. 3 B demonstrates
that pretreatment with Arthrobacter ureafaciens neuramini-
dase also abolished adhesion of NeoLewis CHO cells to im-Table1. Comparison ofGMP-140 or Antibody
Binding to Cells
' Binding assays were performed as described in Materials and Methods.
Anti, sialyl Lewis x binding was tested using the CSLEX mAb and anti, Lewis
x binding was tested using the anti-CD15 mAb (Anti-Leu-M1). The strength
ofbinding ofcells to GMP-140 was determined by assays shown in Fig. 1 . The
expression of sialyl Lewis x and Lewis x was determined by assays shown in
Fig. 5. +++, strong binding; ++, moderate binding; +, slight binding;
-, no binding.
mobilized GMP-140. Neuraminidase treatment of NeoLewis
CHO cells eliminated surface expression of sialyl Lex anti-
gen, as measured by binding of CSLEXI antibody, but
markedly increased expression of Lex, as measured by
binding of anti-LeuMI (Fig. 4) . SinceNeoLewis CHO cells
synthesize the sequence Neu5Aca2-3Ga101-4GIcNAcR, but
not the isomeric sequence Neu5Aca2-6Ga101-4GlcNAc-R,
we conclude that expression of a(2-3)-linked sialic acid is
necessary for binding of these cells to GMP-140.
The requirement for both Lex-related lactosaminoglycans
and ca(2-3)-linked sialic acid for NeoLewis CHO cells to
bind to GMP-140 suggested that sialyl Lex or a related c«(2-
3)sialylated, ca(1-3)fucosylated lactosaminoglycan(s) was a
component ofthe ligand for GMP-140. To explore this possi-
bility further, we correlated the ability of a variety of cell
types to express Lex and sialyl Lex, as measured by ELISA,
with their ability to bind to GMP140. As shown in Fig. 5
and Table I, only cell lines expressing sialyl Lex determin-
ants bound to GMP-140. Adhesion was observed with Neo-
Lewis CHO cells, which synthesize large amounts of sialyl
Lex, and with HL-60 cells, which express intermediate lev-
els of the antigen . Only HT29 cells, which express lower
levels of sialyl Lewis x, failed to adhere to GMP-140-coated
ó
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Figure 2. Effect of mAbs to
GMP-140 on the interaction
between GMP-140 and Neo-
Lewis CHO cells. ['SS]Methi-
onine/cysteine-labeled Neo-
Lewis CHO cells were in-
cubated in microliter wells
precoated with 10 14g/ml of
GMP140 in the presence or
absence of 10,ug/ml mAb (G1
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number of cells bound was
determined as described in
Materials and Methods. All
assays were performed in trip-
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Figure 3. Effect of neuramini-
dase treatment on HL-60 and
NeoLewis CHO cell binding
to immobilized GMP140.
['SS]Methionine/cysteine-la-
beled HL-60 and NeoLewis
CHO cells were first treated
with 1.0 U/ml of Arthrobacter
ureafaciens neuraminidase or
sham-treated with the same
concentration of heated-inac-
tivatedenzyme for 1 h at 37°C.
After enzyme treatment, cells
were placed in microtiter wells
precoated with 10 1.g/mlGMP-
140 and their binding was as-
sessed as described in Materi-
als and Methods. All assays
were performed in duplicate
and results are expressed as
the percentage of the binding
of sham-treated controls.
wells (Fig. 6). F9 teratocarcinoma cells, which express large
amounts of Lex but not sialyl Lex, did not bind to GMP-140.
The results with the F9 cells, in conjunction with previous
studies (Corral et al ., 1990; Moore et al., 1991), indicate
that Lex contains insufficient structural information to sup-
port a biologically relevant interaction with GMP-140.
To further explore the role of sialyl Lex in interactions
with GMP-140, we tested the ability of a mAb to this deter-
minant to inhibit cell binding to GMP140. Anti-sialyl Lex
antibody effectively inhibited both NeoLewis CHO and HL-
60 cell adhesion to immobilized GMP140, whereas anti-
Lex antibody and an IgM mAb to a carbohydrate structure
not found on eukaryotic cells produced comparably modest
inhibition of adhesion (Fig. 7) . The anti-sialyl Lex antibody
Figure 4. Effect of neuramini-
dase treatment on expression
of Lex and Sialyl Lex by Neo-
Lewis CHO cells. NeoLewis
CHO cells were first treated
with 1.0 Ulml of Arthrobacter
ureafaciens neuraminidase or
sham-treated with the same
concentration of heat-inacti-
vated enzyme for 1 h at 37°C.
After enzyme treatment, cells
were fixed onto microtiter wells and incubated with 0.78 1Ag/ml of
anti-sialyl Le% (CSLEX-1) or 0.63 Ag/ml anti-Lex (anti-Leu-Ml)
mAb as described in Materials and Methods. The amount of anti-
body bound was assessed by an ELISA technique using alkaline
phosphatase-conjugated goat anti-mouse IgM antibody. All assays
were performed in duplicate.
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Figure 5 . Binding ofanti-sialyl
Lee and Anti-Lex mAbs to
cell lines . HT29, NeoLewis
CHO, HL-60, and F9 cells
were fixed onto microtiter
wells and incubated with the
indicated concentrations of
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was assessed by an ELISA
technique using alkalinephos-
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scribed under Materials and
Methods . All assays were per-
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inhibited adhesion ofNeoLewis CHO cells more efficiently
than HL-60 cells, suggesting that the surface ligands for
GMP-140 are not identical on these cells . Further support for
this possibility is provided below.
We previously found that treatment of neutrophils with
trypsin abolished specific GMP-140 binding, indicating that
the predominant ligand for GMP-140 on neutrophils is on
surface glycoprotein(s) rather than glycosphingolipid (Moore
et al ., 1991) . Release of NeoLewis CHO cells with light
treatment with trypsin did not affect their ability to bind
to GMP-140. However, more extensive trypsin treatment of
NeoLewisCHO cells significantly reduced their adhesion to
GMP-140, indicating that glycoprotein components, rather
than glycolipids, are also the major ligands for GMP-140 on
these cells (data not shown) .
Di fferences in Reactivity ofGMFL140 with Cells
Expressing Sialyl Lee Determinants
The above studies indicate that cell surface expression of
sialyl Lee or closely related structures are important for in-
teractions with GMP-140. However, the HT29 cell experi-
ments indicate that presence of the sialyl Lee determinant
per se does not allow cells to bind GMP-140 with high affin-
ity. Therefore, GMP-140 might bind with variable affinity to
cells depending on the density and/or the context in which
Figure 6. Binding of HT-29
cells to immobilized GMP-140.
[35S]Methionine/cysteine-la-
beled HT-29 cells and HL-60
cells were incubated in micro-
titer wells containing different
amounts ofimmobilizedGMP-
140 as described in the legend
to Fig. 1 . Cells bound repre-
tracting cells boundin the pres-
ence ofCall fromthose bound
in thepresence of 4mMEDTA . There was no detectable binding of
HT-29 cells in the presence or absence of Ca2' . Duplicate results of
a representative experiment are shown .
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Figure 7 . Effect of anti-sialyl
Lee and Anti-Lei mAbs on
interactions of NeoLewis and
HL-60 cells with immobilized
GMP-140. [35S]Methionine/
cysteine-labeled HL-60 and
NeoLewisCHO cellswerepre-
incubated with the indicated
concentrations of anti-sialyl
Lee (CSLEX-1), anti-Le'
(CSLEX-1), anti-Lex (82H5),
or anti-Forssman antigen (Ml/
87) as described in Materials
and Methods, and the binding
to immobilized GMP-140 (10
Ag/ml) was assessed . The re-
sults are expressed as a per-
cent of cell binding in the ab-
sence of antibody (Mean f
SD, n = 3) . The binding of
cells in the presence ofEDTA
is also indicated .
sialyl Lee or a related structure is presented . To explore this
issue further we examined binding of fluid-phase ['251]-
GMP-140 to HL-60 and NeoLewis CHO cells . As shown in
Fig. 8, GMP-140 bound in a saturable manner to HL-60
cells ; an apparent dissociation constant of 1.9 x 10-1 M -1
was determined by Scatchard analysis (not shown) . In con-
trast, binding ofGMP-140 to NeoLewis CHO cells was not
saturable in the same concentration range . Hence, HL-60
cells have a relatively low number of high affinity binding
sites forGMR140, whereas NeoLewis CHO cells have a rel-
atively high number of low affinity sites .
Discussion
Our results indicate that parental CHO cells, when trans-
fected with a specific ac(1-3/4)fucosyltransferase, express
oligosaccharide ligands for GMP-140 normally present only
on myeloid cells . These cells, termed NeoLewis CHO, ex-
press a variety of neutral and sialylated fucosylated lac-
tosaminoglycans, including the sialyl Lee moiety, Neu-
Aca2-3Galß1-4(Fucal-3)G1cNAcß1-R (Lowe et al., 1990) .
Because parental CHO cells synthesize type II chains con-
taining the disaccharide 3Galol-4G1cNAcOl, but not type
I chains containing the isomeric 3Galol-3G1cNAcol se-
Figure 8 . Steady-state binding
of [I 25I]GMP-140 to HL-60
and NeoLewis CHO cells .
[ 1251]GMP-140 was incubated
101 /~
￿
I
￿
with either HL-60 cells or
m °
￿
I
￿
, / .
￿
-
￿
NeoLewisCHO cells (1.76 x
.- 15
ó
E
51
￿
j~
￿
,
￿
- I
￿
105 cells, final volume = 25
,ul) . Bound [1251]GMP-140
was determined as described
0 .0
￿
0. .5
￿
1 .0
￿
1 .5
￿
under Materials and Methods .
GMP-140 added (pmol)
￿
Nonspecific binding, defined
as [125I]GMP-140 binding in
the presence of4mM EDTA, was subtracted from total binding to
calculate specific binding . Each point represents the mean ofdupli-
cate assays . Results are expressed as fmol GMP-140 bound per 1.76
x 105 cells .
0 2 a s 9 10 12 sents specific binding by sub-
56 1quence, the transferred fucose residue must be linked al-3
to G1cNAc within a N-acetylactosaminoglycan to form the
Lex structure, (R)-3Galßl-4(Fucal-3)G1cNAcß1-R.
Sialic acid residues also constitute a critical part of the
ligand recognized by GMP-140, since neuraminidase treat-
ment abolishes the ability of NeoLewis CHO cells to bind
to the immobilized protein. These sialic acid residues must
be in a2-3 linkage, because parental CHO cells contain
ce(2-3) but not a(2-6)sialyltransferases (Merkle and Cum-
mings, 1988; Lee et al., 1989). The importance of ce2-3-
linked sialic acids for interaction of NeoLewis CHO cells
with GMP140 is consistent with the ability of NDV neur-
aminidase, which cleaves a2-3 but not a2-6 sialic acid link-
ages, to diminish binding of [1251]GMP140 to neutrophils
(Moore et al ., 1991). Corral et al. (1990) concluded that
a2-6 linkages were critical, since NDV neuraminidase did
not inhibit adherence of myeloid cells to activated platelets
which express GMP-140. However, this negative result is
difficult to interpret because the viral particles bearing the
neuraminidase may have induced agglutination ofplatelets to
myeloid cells.
Sialic acid is also an essential component ofthe ligands for
the other known selectins, LAM-1 (LECAM-1) and ELAM-1.
Binding of lymphocytes (Rosen et al., 1985) and a LAM-1/
IgG chimera (True et al., 1990) to peripheral lymph node
high endothelial venules is blocked by pretreatment of the
tissue with neuraminidase. Several different techniques have
demonstrated that ELAM-1 recognizes one or more fuco-
sylated lactosaminoglycans that must contain an ce2-3-linked
sialic acid (Lowe et al., 1990; Goelz et al., 1990; Phillips
et al., 1990; Walz et al ., 1990; Tiemeyer et al., 1991). In
all studies to date, it has been assumed that the sialic acid
involved is the parent molecule N-acetyl-neuraminic acid
(Neu5Ac) . However, the sialic acids are actually a diverse
family of related molecules (Schauer, 1982; Manzi et al .,
1990). A variety of different substitutions are known to sub-
stantially change the size and shape of the parent Neu5Ac
molecule and to alter its biological recognition by enzymes,
antibodies, complement, or viruses (for examples, see Cheresh
et al., 1984; Ravindranath et al., 1985; Corfield et al ., 1986;
Higa et al ., 1985 ; Varki and Kornfeld, 1980; Ahmed and
Bagius, 1989). Such substitutions might significantly increase
or decrease the binding phenomena mediated by selectins.
Recent improvements in technology for study of substituted
sialic acids should make it possible to determine whether
they participate in interactions with selectins.
Larsen et al. (1990) reported that Lex (LNF III, CD15)
mediates adhesion of myeloid cells to GMP-140. This con-
clusion was based on two lines of evidence. First, high
concentrations of an anti-CD15 mAb partially inhibited ad-
hesion of myeloid cells to activated platelets and GMP-140-
transfected COS cells. In contrast, we found that high con-
centrations of an affinity-purified anti-CD15 mAb, 82H5, did
not inhibit binding of ['25I]GMP-140 to neutrophils (Moore
et al., 1991) . In this study, high concentrations of 82H5
partially inhibited adhesion of NeoLewis CHO cells to im-
mobilized GMP-140, even though these cells express no de-
tectable Lex antigen by ELISA. The modest inhibition of
adhesion by 82H5 appears to have been nonspecific, since
a control IgM to the Forsmann antigen also partially in-
hibited adhesion. Since no control IgM antibody was em-
ployed by Larsen et al. (1990), a similar nonspecific inhibi-
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tion of adhesion by the anti-CD15 IgM antibody used in their
study cannot be excluded. These investigators found that an
anti-CD15 IgG mAb also inhibited adhesion, but a control
IgG antibody against an irrelevant carbohydrate epitope
was not employed. The second line of evidence used by
Larsen et al . (1990) to support specific interaction of Le-
with GMP-140 was the observation that high concentrations
of LNF III (ti380 AM), but not the isomeric oligosaccharide
LNF II, inhibited adhesion of myeloid cells to activated
platelets and GMP-140-transfected cells. However, high con-
centrations of a Lex-BSA conjugate do not block binding of
[1z51]GMP140 to neutrophils (Moore et al., 1991) and LNF
III at concentrations as high as 350 uM does not block neu-
trophil adhesion to immobilized GMP-140 (K. L. Moore,
unpublished observations) . The current study demonstrates
that F9 cells and neuraminidase-treated NeoLewis CHO
cells, which express abundant levels of Lex but not sialyl
Lex, do not bind to immobilized GMP-140. We cannot ac-
count for the discrepancy between our data and those of Lar-
sen etal. (1990), except to note that we used two independent
assays to examine the interaction of cellswith purified GMP-
140, whereas Larsen and co-workers examined rosetting of
myeloid cells with GMP140-expressing cells. We conclude
that Lex does not interact in a biologically significant man-
ner with GMP-140.
Protease sensitivity studies suggest that the oligosaccha-
ride structures interacting with GMP-140 on neutrophils
(Moore et al., 1991) and NeoLewis CHO cells (this study)
are carried primarily by glycoproteins rather than glyco-
lipids. A glycolipid ligand would not be expected on the Neo-
Lewis CHO cells, since the simple glycolipids synthesized
by parental CHO cells are not substrates for the transfected
fucosyltransferase and hence cannot express sialyl Lex-re-
lated structures (Smith et al., 1990). The surface proteins
bearing the oligosaccharide structures recognized by GMP-
140 are unlikely to be the same in human myeloid cells and
CHO cells. This suggests that binding of GMP140 to a car-
bohydrate ligand does not require a unique protein-protein
interaction.
Our observations indicate that GMP140 binds to one or
more members of a family of a(2-3)sialylated, a(1-3)fuco-
sylated lactosaminoglycans that can be expressed on both
myeloid and nonmyeloid cells. Previous studies have demon-
strated that there is extensive heterogeneity of these struc-
tures on myeloid cells (Fukuda et al., 1984, 1985). Although
NeoLewis CHO cells express higher levels of sialyl Lex an-
tigen than HL-60 cells, HL-60 cells bind GMP140 with
much higher affinity than do NeoLewis CHO cells. There-
fore, the oligosaccharide ligand(s) recognized with high
affinity by GMP-140 may be more complex than the simple
tetrasaccharide sialyl Lex (Neu5Acc12-3Galß1-4[Fucal-3]-
G1cNAcß-R) . This interpretation is consistent with the ob-
servation that a multivalent sialyl Lex-BSA conjugate does
not inhibit binding of ['25I]GMP140 binding to neutrophils
(Moore et al ., 1991). Perhaps GMP140 binds only with low
affinity to sialyl Lex unless the latter is presented in a spec-
ific orientation, clustered to enhance its avidity, or expressed
as part of a larger fucosylated polylactosaminoglycan . The
protein on myeloid cells to which the carbohydrate ligand(s)
is linked may stabilize the lectin-carbohydrate interaction ei-
ther by presenting the oligosaccharide in the optimum con-
formation or by directly binding to a separate region of
562GMP-140. A high affinity interaction of GMP-140 with its
ligand may be a critical requirement for rapid adhesion of
leukocytes to activated platelets or endothelial cells under
flow conditions found in postcapillary venules (Lawrence
and Springer, 1991) .
Although it is possible that GMP-140 binds to only a single
type of oligosaccharide, it is more likely that it binds with
a range of affinities to structurally related carbohydrates.
Such observations have been made for both plant and animal
lectins and for mAbs to carbohydrate determinants. For ex-
ample, the ß-galactoside-binding lectin L-14 from calf heart
tissue is inhibited by lactose and binds weakly to N-linked
oligosaccharides containing terminal N-acetyllactosamine
units (Sparrow et al., 1987). However, the lectin binds with
much higher affinity to oligosaccharides containing repeating
N-acetyllactosamine units (Merkle and Cummings, 1988;
Zhou and Cummings, 1990). The number and location of
phosphomonoester moieties within high mannose-type oligo-
saccharides influences their interaction with the mannose-6-
phosphate receptor (Varki and Komfeld, 1983). Finally, a
blood group A specific mAb binds with variable affinities to
different oligosaccharides expressing the blood group A epi-
tope (Zopf et al., 1989). Determination of the preferred
ligands for GMP-140 will require their isolation and charac-
terization from myeloid cells.
The carbohydrate recognition properties of GMP-140 and
ELAM-1 demonstrate striking similarities. The NeoLewis
CHO cells, shown here to bind to GMP-140, were previously
shown to interact with ELAM-1 (Lowe et al., 1990). An anti-
sialyl Lex antibody or neuraminidase pretreatment blocks
adhesion ofmyeloid cellsto both GMP-140 (thisstudy; Cor-
ral et al ., 1990; Moore et al., 1991) and ELAM-1 (Phillips
et al., 1990; Walz et al., 1990). These similar observations
are compatible with the possibility that GMP-140 and ELAM-1
recognize carbohydrate ligands with identical affinity and
specificity. However, the amino acid sequences of the lectin
domains of GMP-140 and ELAM-1 are not identical. Thus,
GMP-140 and ELAM-1 might differ in the fine specificity
and/or affinity with which they recognize specific sialylated,
fucosylated lactosaminoglycan structures on target cells.
HT29 cells, which express sialyl Lex determinants, have
been previously shown to bind to ELAM-1 expressed by
cytokine-activated endothelial cells (Rice and Bevilacqua,
1989). We have found that these cells also adhere avidly to
ELAM-1 transfected COS cells (K. L. Moore and R. P
McEver, unpublished observations). In contrast, HT-29 cells
do not bind to GMP-140-transfected COS cells (K. L . Moore
and R. P McEver, unpublished observations) or to purified,
immobilized GMP-140 (Fig. 6) . Although the differential ad-
herence might be due to higher receptor density on the
ELAM-1-transfected cells compared to the GMP-140-trans-
fected cells or the GMP-140-coated plates, it might also
reflect important differences in ligand recognition specifi-
city. Elucidation of possible differences in ligand specificities
will require isolation and comparison of the carbohydrate
structures recognized by both GMP-140 and ELAM-1.
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